About Us

Overview

Founded in San Diego, California, in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under cGMP conditions. CardioCell has an exclusive worldwide license from Stemedica Cell Technologies Inc. for the exploration of therapeutic cardiovascular indications, including acute myocardial Infarction (AMI), chronic heart failure (CHF) and peripheral artery disease (PAD).